CooperCompanies Climbs on Strong Earnings and Upbeat Outlook
The medical device maker lifted its full-year guidance after third-quarter results surpassed Wall Street's expectations.
CooperCompanies saw its shares gain in after-hours trading after the contact lens and surgical device manufacturer posted third-quarter earnings that topped analysts' estimates and raised its financial outlook for the full year, signaling confidence in its ongoing performance.
The San Ramon, California-based company reported revenue of $988.3 million and adjusted earnings of $3.70 per share for the quarter ending July 31. These figures exceeded Wall Street's consensus estimates of $979.8 million in revenue and $3.59 in earnings per share, prompting a positive reaction from investors.
In a statement accompanying the results, CooperCompanies' President and CEO, Al White, commented on the firm's performance, saying, “I am pleased to report that we delivered strong margins, double-digit earnings growth, and robust free cash flow reflecting the operational excellence that remains central to our growth strategy.” He added that the company is “raising earnings guidance to reflect our operational performance and expect improving revenue in Q4 and in fiscal 2026 driven by MyDAY®,” one of its key contact lens products.
For its two main divisions, CooperVision and CooperSurgical, the company reported revenue growth of 6% and 4% respectively. The solid performance across its business lines allowed CooperCompanies to increase its full-year 2025 guidance. The company now projects total revenue in the range of $4.076 billion to $4.096 billion, with non-GAAP diluted earnings per share forecasted between $4.08 and $4.12.
During the third quarter, CooperCompanies also demonstrated a commitment to returning value to shareholders, repurchasing approximately 724,300 shares of its common stock for a total of $52.1 million. The existing share repurchase program still has $163.6 million of availability, leaving the door open for further buybacks.